Global Bullous Pemphigoid Treatment Market Research Report 2023

Bullous pemphigoid is a chronic, inflammatory skin disease that involves the formation of blisters. The bullous may be of different forms such as generalized, vesicular, vegetative, Urticarial, Nodular, Acral or infant forms. The disease is not gender biased and can also occur in younger adults but is rare in infants. The blood blister due to bullous pemphigoid occur in people aging above 70 years.  Bullous pemphigoid occurs when the immune system outbreaks a thin layer of tissue below the outer layer of skin. It is more prevalent in patients suffering from dermatitis and neurological disease, predominantly in stroke and dementia. The bullous pemphigoid blister develops on the skin area that tend to flex such as lower abdomen, upper thigh and armpits. Bullous Pemphigoid causes severe itch, tense bullae, annular lesions, post inflammatory pigmentation, blood stained blister fluids and urticaria-like red skin. Proper medication involved in overturning the immune system plays an important role in treatment of the disease.

The global Bullous Pemphigoid Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Rising geriatric population over the globe increase chances of occurrence of disease and thus the surge in treatment options. Common and non-expensive medication uses in the treatment of disease increases fuels the treatment market. Furthermore, various awareness programs by healthcare organizations and NGOs supports the proliferation of treatment market. Non-availability of healthcare facilities in various less developed regions of globe with high incidence rate of disease restricts the overall market to grow.

This report aims to provide a comprehensive presentation of the global market for Bullous Pemphigoid Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bullous Pemphigoid Treatment.

The Bullous Pemphigoid Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Bullous Pemphigoid Treatment market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Bullous Pemphigoid Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Bullous Pemphigoid Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Immunosuppressant Medication

1.2.3 Steroids

1.2.4 Antibiotics & Antiseptics

1.2.5 Pain Relief Medication

1.3 Market by Application

1.3.1 Global Bullous Pemphigoid Treatment Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospitals Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Mail Order Pharmacies

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Bullous Pemphigoid Treatment Market Perspective (2018-2029)

2.2 Bullous Pemphigoid Treatment Growth Trends by Region

2.2.1 Global Bullous Pemphigoid Treatment Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Bullous Pemphigoid Treatment Historic Market Size by Region (2018-2023)

2.2.3 Bullous Pemphigoid Treatment Forecasted Market Size by Region (2024-2029)

2.3 Bullous Pemphigoid Treatment Market Dynamics

2.3.1 Bullous Pemphigoid Treatment Industry Trends

2.3.2 Bullous Pemphigoid Treatment Market Drivers

2.3.3 Bullous Pemphigoid Treatment Market Challenges

2.3.4 Bullous Pemphigoid Treatment Market Restraints

3.1 Global Top Bullous Pemphigoid Treatment Players by Revenue

3.1.1 Global Top Bullous Pemphigoid Treatment Players by Revenue (2018-2023)

3.1.2 Global Bullous Pemphigoid Treatment Revenue Market Share by Players (2018-2023)

3.2 Global Bullous Pemphigoid Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Bullous Pemphigoid Treatment Revenue

3.4 Global Bullous Pemphigoid Treatment Market Concentration Ratio

3.4.1 Global Bullous Pemphigoid Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Bullous Pemphigoid Treatment Revenue in 2022

3.5 Bullous Pemphigoid Treatment Key Players Head office and Area Served

3.6 Key Players Bullous Pemphigoid Treatment Product Solution and Service

3.7 Date of Enter into Bullous Pemphigoid Treatment Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Bullous Pemphigoid Treatment Historic Market Size by Type (2018-2023)

4.2 Global Bullous Pemphigoid Treatment Forecasted Market Size by Type (2024-2029)

5.1 Global Bullous Pemphigoid Treatment Historic Market Size by Application (2018-2023)

5.2 Global Bullous Pemphigoid Treatment Forecasted Market Size by Application (2024-2029)

6.1 North America Bullous Pemphigoid Treatment Market Size (2018-2029)

6.2 North America Bullous Pemphigoid Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Bullous Pemphigoid Treatment Market Size by Country (2018-2023)

6.4 North America Bullous Pemphigoid Treatment Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Bullous Pemphigoid Treatment Market Size (2018-2029)

7.2 Europe Bullous Pemphigoid Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Bullous Pemphigoid Treatment Market Size by Country (2018-2023)

7.4 Europe Bullous Pemphigoid Treatment Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Bullous Pemphigoid Treatment Market Size (2018-2029)

8.2 Asia-Pacific Bullous Pemphigoid Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Bullous Pemphigoid Treatment Market Size by Region (2018-2023)

8.4 Asia-Pacific Bullous Pemphigoid Treatment Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Bullous Pemphigoid Treatment Market Size (2018-2029)

9.2 Latin America Bullous Pemphigoid Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Bullous Pemphigoid Treatment Market Size by Country (2018-2023)

9.4 Latin America Bullous Pemphigoid Treatment Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Bullous Pemphigoid Treatment Market Size (2018-2029)

10.2 Middle East & Africa Bullous Pemphigoid Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Bullous Pemphigoid Treatment Market Size by Country (2018-2023)

10.4 Middle East & Africa Bullous Pemphigoid Treatment Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Pfizer

11.1.1 Pfizer Company Detail

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Bullous Pemphigoid Treatment Introduction

11.1.4 Pfizer Revenue in Bullous Pemphigoid Treatment Business (2018-2023)

11.1.5 Pfizer Recent Development

11.2 Aqua Pharmaceuticals

11.2.1 Aqua Pharmaceuticals Company Detail

11.2.2 Aqua Pharmaceuticals Business Overview

11.2.3 Aqua Pharmaceuticals Bullous Pemphigoid Treatment Introduction

11.2.4 Aqua Pharmaceuticals Revenue in Bullous Pemphigoid Treatment Business (2018-2023)

11.2.5 Aqua Pharmaceuticals Recent Development

11.3 Sirius Laboratories

11.3.1 Sirius Laboratories Company Detail

11.3.2 Sirius Laboratories Business Overview

11.3.3 Sirius Laboratories Bullous Pemphigoid Treatment Introduction

11.3.4 Sirius Laboratories Revenue in Bullous Pemphigoid Treatment Business (2018-2023)

11.3.5 Sirius Laboratories Recent Development

11.4 DUBLIN Pharmaceuticals

11.4.1 DUBLIN Pharmaceuticals Company Detail

11.4.2 DUBLIN Pharmaceuticals Business Overview

11.4.3 DUBLIN Pharmaceuticals Bullous Pemphigoid Treatment Introduction

11.4.4 DUBLIN Pharmaceuticals Revenue in Bullous Pemphigoid Treatment Business (2018-2023)

11.4.5 DUBLIN Pharmaceuticals Recent Development

11.5 Teva Pharmaceuticals

11.5.1 Teva Pharmaceuticals Company Detail

11.5.2 Teva Pharmaceuticals Business Overview

11.5.3 Teva Pharmaceuticals Bullous Pemphigoid Treatment Introduction

11.5.4 Teva Pharmaceuticals Revenue in Bullous Pemphigoid Treatment Business (2018-2023)

11.5.5 Teva Pharmaceuticals Recent Development

11.6 Astellas Pharma

11.6.1 Astellas Pharma Company Detail

11.6.2 Astellas Pharma Business Overview

11.6.3 Astellas Pharma Bullous Pemphigoid Treatment Introduction

11.6.4 Astellas Pharma Revenue in Bullous Pemphigoid Treatment Business (2018-2023)

11.6.5 Astellas Pharma Recent Development

11.7 Aegis Pharmaceuticals

11.7.1 Aegis Pharmaceuticals Company Detail

11.7.2 Aegis Pharmaceuticals Business Overview

11.7.3 Aegis Pharmaceuticals Bullous Pemphigoid Treatment Introduction

11.7.4 Aegis Pharmaceuticals Revenue in Bullous Pemphigoid Treatment Business (2018-2023)

11.7.5 Aegis Pharmaceuticals Recent Development

11.8 Sun Pharmaceuticals

11.8.1 Sun Pharmaceuticals Company Detail

11.8.2 Sun Pharmaceuticals Business Overview

11.8.3 Sun Pharmaceuticals Bullous Pemphigoid Treatment Introduction

11.8.4 Sun Pharmaceuticals Revenue in Bullous Pemphigoid Treatment Business (2018-2023)

11.8.5 Sun Pharmaceuticals Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Bullous Pemphigoid Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Immunosuppressant Medication

    Table 3. Key Players of Steroids

    Table 4. Key Players of Antibiotics & Antiseptics

    Table 5. Key Players of Pain Relief Medication

    Table 6. Global Bullous Pemphigoid Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Bullous Pemphigoid Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 8. Global Bullous Pemphigoid Treatment Market Size by Region (2018-2023) & (US$ Million)

    Table 9. Global Bullous Pemphigoid Treatment Market Share by Region (2018-2023)

    Table 10. Global Bullous Pemphigoid Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 11. Global Bullous Pemphigoid Treatment Market Share by Region (2024-2029)

    Table 12. Bullous Pemphigoid Treatment Market Trends

    Table 13. Bullous Pemphigoid Treatment Market Drivers

    Table 14. Bullous Pemphigoid Treatment Market Challenges

    Table 15. Bullous Pemphigoid Treatment Market Restraints

    Table 16. Global Bullous Pemphigoid Treatment Revenue by Players (2018-2023) & (US$ Million)

    Table 17. Global Bullous Pemphigoid Treatment Market Share by Players (2018-2023)

    Table 18. Global Top Bullous Pemphigoid Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bullous Pemphigoid Treatment as of 2022)

    Table 19. Ranking of Global Top Bullous Pemphigoid Treatment Companies by Revenue (US$ Million) in 2022

    Table 20. Global 5 Largest Players Market Share by Bullous Pemphigoid Treatment Revenue (CR5 and HHI) & (2018-2023)

    Table 21. Key Players Headquarters and Area Served

    Table 22. Key Players Bullous Pemphigoid Treatment Product Solution and Service

    Table 23. Date of Enter into Bullous Pemphigoid Treatment Market

    Table 24. Mergers & Acquisitions, Expansion Plans

    Table 25. Global Bullous Pemphigoid Treatment Market Size by Type (2018-2023) & (US$ Million)

    Table 26. Global Bullous Pemphigoid Treatment Revenue Market Share by Type (2018-2023)

    Table 27. Global Bullous Pemphigoid Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 28. Global Bullous Pemphigoid Treatment Revenue Market Share by Type (2024-2029)

    Table 29. Global Bullous Pemphigoid Treatment Market Size by Application (2018-2023) & (US$ Million)

    Table 30. Global Bullous Pemphigoid Treatment Revenue Market Share by Application (2018-2023)

    Table 31. Global Bullous Pemphigoid Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 32. Global Bullous Pemphigoid Treatment Revenue Market Share by Application (2024-2029)

    Table 33. North America Bullous Pemphigoid Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 34. North America Bullous Pemphigoid Treatment Market Size by Country (2018-2023) & (US$ Million)

    Table 35. North America Bullous Pemphigoid Treatment Market Size by Country (2024-2029) & (US$ Million)

    Table 36. Europe Bullous Pemphigoid Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 37. Europe Bullous Pemphigoid Treatment Market Size by Country (2018-2023) & (US$ Million)

    Table 38. Europe Bullous Pemphigoid Treatment Market Size by Country (2024-2029) & (US$ Million)

    Table 39. Asia-Pacific Bullous Pemphigoid Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 40. Asia-Pacific Bullous Pemphigoid Treatment Market Size by Region (2018-2023) & (US$ Million)

    Table 41. Asia-Pacific Bullous Pemphigoid Treatment Market Size by Region (2024-2029) & (US$ Million)

    Table 42. Latin America Bullous Pemphigoid Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 43. Latin America Bullous Pemphigoid Treatment Market Size by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Bullous Pemphigoid Treatment Market Size by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Bullous Pemphigoid Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 46. Middle East & Africa Bullous Pemphigoid Treatment Market Size by Country (2018-2023) & (US$ Million)

    Table 47. Middle East & Africa Bullous Pemphigoid Treatment Market Size by Country (2024-2029) & (US$ Million)

    Table 48. Pfizer Company Detail

    Table 49. Pfizer Business Overview

    Table 50. Pfizer Bullous Pemphigoid Treatment Product

    Table 51. Pfizer Revenue in Bullous Pemphigoid Treatment Business (2018-2023) & (US$ Million)

    Table 52. Pfizer Recent Development

    Table 53. Aqua Pharmaceuticals Company Detail

    Table 54. Aqua Pharmaceuticals Business Overview

    Table 55. Aqua Pharmaceuticals Bullous Pemphigoid Treatment Product

    Table 56. Aqua Pharmaceuticals Revenue in Bullous Pemphigoid Treatment Business (2018-2023) & (US$ Million)

    Table 57. Aqua Pharmaceuticals Recent Development

    Table 58. Sirius Laboratories Company Detail

    Table 59. Sirius Laboratories Business Overview

    Table 60. Sirius Laboratories Bullous Pemphigoid Treatment Product

    Table 61. Sirius Laboratories Revenue in Bullous Pemphigoid Treatment Business (2018-2023) & (US$ Million)

    Table 62. Sirius Laboratories Recent Development

    Table 63. DUBLIN Pharmaceuticals Company Detail

    Table 64. DUBLIN Pharmaceuticals Business Overview

    Table 65. DUBLIN Pharmaceuticals Bullous Pemphigoid Treatment Product

    Table 66. DUBLIN Pharmaceuticals Revenue in Bullous Pemphigoid Treatment Business (2018-2023) & (US$ Million)

    Table 67. DUBLIN Pharmaceuticals Recent Development

    Table 68. Teva Pharmaceuticals Company Detail

    Table 69. Teva Pharmaceuticals Business Overview

    Table 70. Teva Pharmaceuticals Bullous Pemphigoid Treatment Product

    Table 71. Teva Pharmaceuticals Revenue in Bullous Pemphigoid Treatment Business (2018-2023) & (US$ Million)

    Table 72. Teva Pharmaceuticals Recent Development

    Table 73. Astellas Pharma Company Detail

    Table 74. Astellas Pharma Business Overview

    Table 75. Astellas Pharma Bullous Pemphigoid Treatment Product

    Table 76. Astellas Pharma Revenue in Bullous Pemphigoid Treatment Business (2018-2023) & (US$ Million)

    Table 77. Astellas Pharma Recent Development

    Table 78. Aegis Pharmaceuticals Company Detail

    Table 79. Aegis Pharmaceuticals Business Overview

    Table 80. Aegis Pharmaceuticals Bullous Pemphigoid Treatment Product

    Table 81. Aegis Pharmaceuticals Revenue in Bullous Pemphigoid Treatment Business (2018-2023) & (US$ Million)

    Table 82. Aegis Pharmaceuticals Recent Development

    Table 83. Sun Pharmaceuticals Company Detail

    Table 84. Sun Pharmaceuticals Business Overview

    Table 85. Sun Pharmaceuticals Bullous Pemphigoid Treatment Product

    Table 86. Sun Pharmaceuticals Revenue in Bullous Pemphigoid Treatment Business (2018-2023) & (US$ Million)

    Table 87. Sun Pharmaceuticals Recent Development

    Table 88. Research Programs/Design for This Report

    Table 89. Key Data Information from Secondary Sources

    Table 90. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Bullous Pemphigoid Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Bullous Pemphigoid Treatment Market Share by Type: 2022 VS 2029

    Figure 3. Immunosuppressant Medication Features

    Figure 4. Steroids Features

    Figure 5. Antibiotics & Antiseptics Features

    Figure 6. Pain Relief Medication Features

    Figure 7. Global Bullous Pemphigoid Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 8. Global Bullous Pemphigoid Treatment Market Share by Application: 2022 VS 2029

    Figure 9. Hospitals Pharmacies Case Studies

    Figure 10. Retail Pharmacies Case Studies

    Figure 11. Mail Order Pharmacies Case Studies

    Figure 12. Bullous Pemphigoid Treatment Report Years Considered

    Figure 13. Global Bullous Pemphigoid Treatment Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 14. Global Bullous Pemphigoid Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 15. Global Bullous Pemphigoid Treatment Market Share by Region: 2022 VS 2029

    Figure 16. Global Bullous Pemphigoid Treatment Market Share by Players in 2022

    Figure 17. Global Top Bullous Pemphigoid Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bullous Pemphigoid Treatment as of 2022)

    Figure 18. The Top 10 and 5 Players Market Share by Bullous Pemphigoid Treatment Revenue in 2022

    Figure 19. North America Bullous Pemphigoid Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 20. North America Bullous Pemphigoid Treatment Market Share by Country (2018-2029)

    Figure 21. United States Bullous Pemphigoid Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Canada Bullous Pemphigoid Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Europe Bullous Pemphigoid Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Europe Bullous Pemphigoid Treatment Market Share by Country (2018-2029)

    Figure 25. Germany Bullous Pemphigoid Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. France Bullous Pemphigoid Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. U.K. Bullous Pemphigoid Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Italy Bullous Pemphigoid Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Russia Bullous Pemphigoid Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Nordic Countries Bullous Pemphigoid Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Asia-Pacific Bullous Pemphigoid Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Asia-Pacific Bullous Pemphigoid Treatment Market Share by Region (2018-2029)

    Figure 33. China Bullous Pemphigoid Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Japan Bullous Pemphigoid Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. South Korea Bullous Pemphigoid Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Southeast Asia Bullous Pemphigoid Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. India Bullous Pemphigoid Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Australia Bullous Pemphigoid Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Latin America Bullous Pemphigoid Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Latin America Bullous Pemphigoid Treatment Market Share by Country (2018-2029)

    Figure 41. Mexico Bullous Pemphigoid Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Brazil Bullous Pemphigoid Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Middle East & Africa Bullous Pemphigoid Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Middle East & Africa Bullous Pemphigoid Treatment Market Share by Country (2018-2029)

    Figure 45. Turkey Bullous Pemphigoid Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Saudi Arabia Bullous Pemphigoid Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Pfizer Revenue Growth Rate in Bullous Pemphigoid Treatment Business (2018-2023)

    Figure 48. Aqua Pharmaceuticals Revenue Growth Rate in Bullous Pemphigoid Treatment Business (2018-2023)

    Figure 49. Sirius Laboratories Revenue Growth Rate in Bullous Pemphigoid Treatment Business (2018-2023)

    Figure 50. DUBLIN Pharmaceuticals Revenue Growth Rate in Bullous Pemphigoid Treatment Business (2018-2023)

    Figure 51. Teva Pharmaceuticals Revenue Growth Rate in Bullous Pemphigoid Treatment Business (2018-2023)

    Figure 52. Astellas Pharma Revenue Growth Rate in Bullous Pemphigoid Treatment Business (2018-2023)

    Figure 53. Aegis Pharmaceuticals Revenue Growth Rate in Bullous Pemphigoid Treatment Business (2018-2023)

    Figure 54. Sun Pharmaceuticals Revenue Growth Rate in Bullous Pemphigoid Treatment Business (2018-2023)

    Figure 55. Bottom-up and Top-down Approaches for This Report

    Figure 56. Data Triangulation

    Figure 57. Key Executives Interviewed